Multiple Myeloma Risks | Tara Gregory, M.D. | Colorado Blood Cancer Institute

Multiple Myeloma Risks | Tara Gregory, M.D. | Colorado Blood Cancer Institute


– So in terms of the
risks of multiple myeloma, it’s really changing,
and it’s a growing field in terms of how we determine that. It used to be that we had something called the Durie-Salmon staging. We started using a different risk score, called the International Staging Score, for multiple myeloma, and that was just based
on two blood tests. Now we’re starting to
learn that myeloma cells can have different DNA mutations, or different changes in the DNA that can make it a good myeloma that will be easy to treat, or a myeloma that’s not
going to behave as well. And it’s important to understand that, because once we get all of that data, including some special scans to look at the bones, either MRIs, PET-CTs, or plain X-rays, blood tests, urine tests, including a bone marrow biopsy, that can help us determine what’s the best treatment for you, based on your myeloma? And not only what’s the best treatment for you, right now, but what’s the overall treatment plan? What I’d like to explain
to patients with myeloma is that this isn’t currently
a disease that we can cure. But, hopefully, this is a disease that we can turn into something that you can live with and not die from.